Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 10

ESCI
Impact Factor

Blood and Lymphatic Cancer: Targets and Therapy

ISSN: 1179-9889


       

Archive: Volume 10, 2020

Review

Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy

Sigmund AM, Sahasrabudhe KD, Bhatnagar B

Blood and Lymphatic Cancer: Targets and Therapy 2020, 10:7-20

Published Date: 3 November 2020

Original Research

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

Ujjani C, Mato A, Hill BT, Allan JN, Lansigan E, Jacobs R, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M

Blood and Lymphatic Cancer: Targets and Therapy 2020, 10:1-5

Published Date: 24 August 2020